Cigna 2011 Annual Report Download - page 161
Download and view the complete annual report
Please find page 161 of the 2011 Cigna annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.FS-9CIGNA CORPORATION2011 Form10K
ITEM 15 Exhibits and Financial Statement Schedules
PART IV
e Company may redeem the Notesissued in 2010 at any time, in
whole or in part, at a redemption price equal to the greater of:
•100% of the principal amount of the Notesto be redeemed; or
•
the present value of the remaining principal and interest payments
on the Notesbeing redeemed discounted at the applicable Treasury
Rate plus 25 basis points.
Maturities of debt are as follows (inmillions): none in 2012,
2013,2014,2015, $600 in 2016 and the remainder in years after 2016.
Interest expense on long-term and short-term debt was $195million
in 2011, $176million in 2010, and $160million in 2009. Interest
paid on long-term and short-term debt was $179million in 2011,
$175million in 2010, and $153million in 2009.
Note3—Intercompany liabilities consist primarily of loans payable to
Cigna Holdings,Inc. of $460million as of December31,2011 and
$3.7billion as of December31,2010. e proceeds of the debt issuance
in November2011 of $2.1billion (see Note2) and the equity issuance
of $629million (see Note5) were used to reduce the intercompany loan
payable balance with Cigna Holdings and ultimately used to fund the
HealthSpring acquisition in 2012. Interest was accrued at an average
monthly rate of 0.63% for 2011 and 0.61% for 2010.
Note4—As of December31,2011, the Company had guarantees and
similar agreements in place to secure payment obligations or solvency
requirements of certain wholly owned subsidiaries as follows:
•
e Company has arranged for bank letters of credit in the amount
of $36million in support of its indirect wholly owned subsidiaries.
As of December31,2011, approximately $33million of the letters
of credit were issued to support Cigna Global Reinsurance Company,
an indirect wholly owned subsidiary domiciled in Bermuda. ese
letters of credit primarily secure the payment of insureds’ claims
from run-o reinsurance operations. As of December31,2011,
approximately $3million of the letters of credit were issued to
provide collateral support for various other indirectly wholly owned
subsidiaries of the Company.
•
Various indirect, wholly owned subsidiaries have obtained surety bonds
in the normal course of business. If there is a claim on a surety bond
and the subsidiary is unable to pay, the Company guarantees payment
to the company issuing the surety bond. e aggregate amount of
such surety bonds as of Decemberwas $24million.
•
e Company is obligated under a $27million letter of credit required
by the insurer of its high-deductible self-insurance programs to
indemnify the insurer for claim liabilities that fall within deductible
amounts for policy years dating back to 1994.
•
e Company also provides solvency guarantees aggregating $34million
under state and federal regulations in support of its indirect wholly
owned medical HMOs in several states.
•
e Company has arranged a $55million letter of credit in support
of Cigna Europe Insurance Company, an indirect wholly owned
subsidiary. e Company has agreed to indemnify the banks providing
the letters of credit in the event of any draw. Cigna Europe Insurance
Company is the holder of the letters of credit.
•
In addition, the Company has agreed to indemnify payment of
losses included in Cigna Europe Insurance Company’s reserves
on the assumed reinsurance business transferred from ACE. As of
December31,2011, the reserve was $88million.
In 2011, no payments have been made on these guarantees and none
are pending. e Company provided other guarantees to subsidiaries
that, in the aggregate, do not represent a material risk to the Company’s
results of operations, liquidity or nancial condition.
Note5 - On November16,2011, the Company issued 15.2million shares
of its common stock at $42.75 per share. Proceeds were $650million
($629million net of underwriting discount and fees). e proceeds
were used to reduce the intercompany loan payable balance with Cigna
Holdings and ultimately used to fund the HealthSpring acquisition
in January2012.
Contents
Q